Topical spreading applicator

- ACRUX DDS PTY LTD
Skip to: Description  ·  Claims  ·  References Cited  · Patent History  ·  Patent History
Description

FIG. 1 is an isometric view of a topical spreading applicator of the claimed design;

FIG. 2 is a front view of the topical spreading applicator shown in FIG. 1;

FIG. 3 is a back view of the topical spreading applicator shown in FIG. 1;

FIG. 4 is a left side view of the topical spreading applicator shown in FIG. 1;

FIG. 5 is a right side view of the topical spreading applicator shown in FIG. 1;

FIG. 6 is a top view of the topical spreading applicator shown in FIG. 1; and,

FIG. 7 is a bottom view of the topical spreading applicator shown in FIG. 1.

In the drawings, the broken lines depict environmental subject matter only and form no part of the claimed design.

Claims

We claim the ornamental design for a topical spreading applicator, as shown and described.

Referenced Cited
U.S. Patent Documents
1573224 March 1924 Condit
1710816 June 1928 Evans
1925019 August 1933 Wilson
1982833 December 1934 Schmerler
2361407 October 1944 McNair
2608705 August 1946 Duff
3462230 August 1969 Chester
3685913 August 1972 Pass
3887115 June 1975 Petterson
4264586 April 28, 1981 Callingham
4483636 November 20, 1984 Meyer
4726700 February 23, 1988 Gray
4739778 April 26, 1988 Christie
4787374 November 29, 1988 De Yarman
5122383 June 16, 1992 Heiber et al.
5186358 February 16, 1993 McVay
5254338 October 19, 1993 Sakai et al.
5558874 September 24, 1996 Haber et al.
5567073 October 22, 1996 De Laforcade et al.
5568669 October 29, 1996 Godown
5613958 March 25, 1997 Kochinke et al.
5772347 June 30, 1998 Gueret
5780050 July 14, 1998 Jain et al.
5788983 August 4, 1998 Chien et al.
5792469 August 11, 1998 Tipton et al.
D399744 October 20, 1998 Gross
5847363 December 8, 1998 Debourg et al.
5904151 May 18, 1999 Gueret
5968919 October 19, 1999 Samour et al.
6010716 January 4, 2000 Saunal et al.
6211250 April 3, 2001 Tomilinson et al.
6238284 May 29, 2001 Dittgen et al.
6299900 October 9, 2001 Reed et al.
6309128 October 30, 2001 Griebel et al.
6315482 November 13, 2001 Girardot et al.
6325565 December 4, 2001 Girardot et al.
6503894 January 7, 2003 Dudley et al.
6562790 May 13, 2003 Chein et al.
D477664 July 22, 2003 Wong
D478809 August 26, 2003 Cummings
D483258 December 9, 2003 Cummings
6666216 December 23, 2003 Bourjal
6681945 January 27, 2004 Harrold
6682757 January 27, 2004 Wright
D492592 July 6, 2004 Palomino, Jr.
6773187 August 10, 2004 Gueret
6818226 November 16, 2004 Reed et al.
6902741 June 7, 2005 Grawe et al.
6916486 July 12, 2005 Klose et al.
6916487 July 12, 2005 Klose et al.
6923983 August 2, 2005 Morgan et al.
6945723 September 20, 2005 Gueret
6964777 November 15, 2005 Klose et al.
6998138 February 14, 2006 Chew et al.
7094422 August 22, 2006 Chew et al.
D535893 January 30, 2007 Shurtleff
7344328 March 18, 2008 McAuley
7387789 June 17, 2008 Klose et al.
7438203 October 21, 2008 Reed et al.
7441974 October 28, 2008 Gueret
7828166 November 9, 2010 Sprick
7927034 April 19, 2011 Staniforth et al.
7955016 June 7, 2011 Gueret
D649456 November 29, 2011 Baker et al.
8071075 December 6, 2011 Reed et al.
8177449 May 15, 2012 Bayly et al.
D661200 June 5, 2012 Subler
D667309 September 18, 2012 Delaney et al.
8357393 January 22, 2013 Morgan et al.
8419307 April 16, 2013 Bayly et al.
8435944 May 7, 2013 Di Pietro et al.
D693059 November 5, 2013 Tani
D693919 November 19, 2013 Miu
D708784 July 8, 2014 Kim
D727567 April 21, 2015 Bunkley
20040009214 January 15, 2004 Klose et al.
20040126355 July 1, 2004 Childers
20050181032 August 18, 2005 Wilkins et al.
20050186141 August 25, 2005 Gonda et al.
20060116694 June 1, 2006 Hogan et al.
20060280783 December 14, 2006 Di Pietro et al.
20070071803 March 29, 2007 Reed et al.
20070275943 November 29, 2007 Morgan et al.
20080131494 June 5, 2008 Reed et al.
20080170904 July 17, 2008 Bayly et al.
20090098081 April 16, 2009 MacDonald et al.
20100166674 July 1, 2010 Morgan et al.
20100322884 December 23, 2010 Di Pietro et al.
20150023721 January 22, 2015 Gieux et al.
Foreign Patent Documents
28 36 752 August 1978 DE
35 26 109 January 1987 DE
197 28 447 July 1997 DE
0 549 049 May 1996 EP
2 581 569 November 1986 FR
1110824 April 1968 GB
1 158 412 July 1969 GB
WO 91/18535 December 1991 WO
WO 93/25168 December 1993 WO
WO 99/24041 May 1999 WO
WO 00/06464 February 2000 WO
WO 00/45795 August 2000 WO
WO 01/76972 October 2001 WO
WO 2004/009457 January 2004 WO
WO 2005/039531 May 2005 WO
WO 2005/051771 June 2005 WO
WO 2006/005135 January 2006 WO
WO 2006/027278 March 2006 WO
WO-2013/000778 January 2013 WO
Other references
  • Overall Learnings. Clarification on Current Concept Safety Level.
  • Standard Child Safety Features To Leverage.
  • Physicians' Desk Reference, Thomson PDR, 58th ed., pp. 711-713 and 3239-3241, 2004.
  • Physicians' Desk Reference, Thomson PDR, 60th ed., pp. 722-724 and 3330-3334, 2006.
  • Supplementary European Search Report issued on Mar. 29, 2011 in application No. 07701469.
  • Notice of Allowance issued on Jan. 23, 2012 in U.S. Appl. No. 11/678,673 (U.S. Pat. No. 8,177,449).
  • Office Action issued on Oct. 12, 2011 in U.S. Appl. No. 11/678,673 (U.S. Pat. No. 8,177,449).
  • Office Action issued on Apr. 4, 2011 in U.S. Appl. No. 11/678,673 (U.S. Pat. No. 8,177,449).
  • Office Action issued on Dec. 9, 2010 in U.S. Appl. No. 11/678,673 (U.S. Pat. No. 8,177,449).
  • Office Action issued on Jul. 3, 2012 in U.S. Appl. No. 13/464,556 (U.S. Pat. No. 8,419,307).
  • Notice of Allowance issued on Sep. 7, 2012 in U.S. Appl. No. 13/464,556 (U.S. Pat. No. 8,419,307).
  • Notice of Allowance issued on Jan. 15, 2013 in U.S. Appl. No. 13/464,556 (U.S. Pat. No. 8,419,307).
  • Maibach et al., “Regional Variation in Percutaneous Penetration in Man: Pesticides,” Arch. Environ. Health, vol. 23, pp. 208-211, Sep. 1971.
  • Wester et al., “Regional Variation in Percutaneous Absorption,” Percutaneous Absorption Drugs-Cosmetics-Mechanisms-Methodology, 3rd Ed., 1999, pp. 107-116.
  • E. Ben-Galim et al., “Topically Applied Testosterone and Phallic Growth. Its Effects in Male Children With Hypopituitarism and Microphallus”, American Journal of Disease and Children (1960), (1980), vol. 134, pp. 296-298.
  • Berti et al., “Transcutaneous drug delivery: a practical review,” Mayo Clin. Proc., vol. 70, No. 6, pp. 581-586, Jun. 1995.
  • Morgan et al., “Enhanced Transdermal Delivery of Sex Hormones with Metered-Dose Topical Aerosols from Discovery to Clinical Evaluation,” Pharm. Res., vol. 14, p. S-101, Nov. 1997.
  • Finnin et al., “Enhancement of Epidermal Penetration of NSAIDS by Padimate O, Octyl Slicylate and Octyl Methoxycinnamate,” Pharm. Res., vol. 14, p. S-304, Abstract, Nov. 1997.
  • Lee et al., “The Role of Corticosteroids in Dermatology,” Austr. Prescr. vol. 21, pp. 9-11, Jan. 1998.
  • Morgan et al., “Enhanced Skin Permeation of Sex Hormones with Novel Topical Spray Vehicles,” J. Pharm. Sci..,vol. 87, pp. 1213-1218, Oct. 1998.
  • Wang et al., “Transdermal Testosterone Gel Improves Sexual Function Mood, Muscle Strength , and Body Composition Parameters in Hypogonadal Men,” J. Clin. Endocrinology & Metabolism, vol. 85, pp. 2839-2853, Aug. 2000.
  • Morgan, Timothy M., “Enhanced Transdermal Delivery of Sex Hormones in Swine with a Novel Topical Aerosol”, Journal of Pharmaceutical Sciences, vol. 87, No. 10, pp. 1219-1225 (1998).
  • Wang et al., “Pharmocokinetics of Transdermal Testosterone Gel in Hypogonadal Men: Application of Gel at One Site Versus Four Sites: A General Clinical Research Center Study,” The Journal of Clinical Endrocrinology & Metabolism, vol. 85, No. 3, pp. 964-969, 2000.
  • Solvay Pharmaceuticals; “AndroGel® testosterone gel,” prescribing information, Sep. 2009.
  • Solvay Pharmacuticals, “AndroGel® testosterone gel,” medication guide, Sep. 2009.
  • Auxilium Pharmacuticals, “Testim® testosterone gel,” prescribing information, Sep. 2009.
  • Auxilium Pharmacuticals, “Testim® testosterone gel,” medication guide, Sep. 2009.
  • Cutter, “Compounded Percutaneous Testosterone Gel: Use and Effects in Hypogonadal Men,” JABFP, vol. 14, No. 1, pp. 22-32, Feb. 2001.
  • Swerdloff et al., “Long-Term Pharmacokinetics of Transdermal Testosterone Gel in Hypogonadal Men,” J. Endocrinology and Metablolism., vol. 85, pp. 4500-4510, Dec. 2000.
  • US Office Action in U.S. Appl. No. 29/473,895 dated May 27, 2015.
  • Notice of Allowance And Issue Fee(s) Due dated Oct. 15, 2015 in related U.S. Appl. No. 29/473,895.
Patent History
Patent number: D749225
Type: Grant
Filed: Nov 26, 2013
Date of Patent: Feb 9, 2016
Assignee: ACRUX DDS PTY LTD (Victoria)
Inventors: Shu Kuen Chang (Evanston, IL), Alain Regard (Beynost), Anastasios G. Karahalios (Chicago, IL), Mark LaFever (Indianapolis, IN)
Primary Examiner: Robert M Spear
Assistant Examiner: Darcey E Heflin
Application Number: 29/473,900
Classifications
Current U.S. Class: Article For Topical Care, Nursing Or Rehabilitation (52) (D24/188); D9/723